mlsanityData to 14 Oct 2026

Applications of Machine Learning in Biopharmaceutical Process Development and Manufacturing: Current Trends, Challenges, and Opportunities

arXiv 2310.09991 ↗First posted 16 Oct 2023cs.LGcited by 2

Not on the map. Why?

Abstract (arXiv)

While machine learning (ML) has made significant contributions to the biopharmaceutical field, its applications are still in the early stages in terms of providing direct support for quality-by-design based development and manufacturing of biopharmaceuticals, hindering the enormous potential for bioprocesses automation from their development to manufacturing. However, the adoption of ML-based models instead of conventional multivariate data analysis methods is significantly increasing due to the accumulation of large-scale production data. This trend is primarily driven by the real-time monitoring of process variables and quality attributes of biopharmaceutical products through the implementation of advanced process analytical technologies. Given the complexity and multidimensionality of a bioproduct design, bioprocess development, and product manufacturing data, ML-based approaches are increasingly being employed to achieve accurate, flexible, and high-performing predictive models to address the problems of analytics, monitoring, and control within the biopharma field. This paper aims to provide a comprehensive review of the current applications of ML solutions in a bioproduct design, monitoring, control, and optimisation of upstream, downstream, and product formulation processes. Finally, this paper thoroughly discusses the main challenges related to the bioprocesses themselves, process data, and the use of machine learning models in biopharmaceutical process development and manufacturing. Moreover, it offers further insights into the adoption of innovative machine learning methods and novel trends in the development of new digital biopharma solutions.

Key facts. Cited by 2 papers in the map (data through 14 Oct 2026). Builds on 8 of its 491 references that are in the map. First posted on arXiv 16 Oct 2023.

Builds on

8 of 491 references.

References · 8

  1. 2020ProGen: Language Modeling for Protein Generationcited by 128
  2. 2021Automated Deep Learning: Neural Architecture Search Is Not the Endcited by 13
  3. 2020AutonoML: Towards an Integrated Framework for Autonomous Machine Learningcited by 9
  4. 2021Benchmarking deep generative models for diverse antibody sequence designcited by 9
  5. 2020A Review of Meta-level Learning in the Context of Multi-component, Multi-level Evolving Prediction Systemscited by 7
  6. 2022The Roles and Modes of Human Interactions with Automated Machine Learning Systemscited by 4
  7. 2022When Bioprocess Engineering Meets Machine Learning: A Survey from the Perspective of Automated Bioprocess Developmentcited by 4
  8. 2022The Technological Emergence of AutoML: A Survey of Performant Software and Applications in the Context of Industrycited by 2

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2024: 1; 2025: 0; 2026: 1.

2 papers.